Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
167.13
131.31
196.25
277.13
186.42
120.28
251.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
167.13
131.31
196.25
277.13
186.42
120.28
251.45
Raw Material Cost
46.33
43.29
77.10
109.22
56.14
53.58
22.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.04
0.66
1.80
19.63
27.42
35.74
48.28
Selling and Distribution Expenses
81.55
52.79
70.06
57.48
64.44
41.88
37.73
Other Expenses
1.84
2.48
3.44
4.95
2.97
-0.52
-2.04
Total Expenditure (Excl Depreciation)
149.31
121.49
183.41
235.84
177.69
126.00
87.73
Operating Profit (PBDIT) excl Other Income
17.8
9.8
12.8
41.3
8.7
-5.699999999999999
163.70000000000002
Other Income
74.85
54.49
30.58
37.93
11.15
850.90
52.48
Operating Profit (PBDIT)
135.25
101.73
86.81
130.17
47.85
888.91
232.90
Interest
3.04
0.66
1.80
19.63
27.42
35.74
48.28
Exceptional Items
-92.31
0.00
-5.61
-12.30
-3.00
-12.80
5.40
Gross Profit (PBDT)
120.80
88.03
119.14
167.91
130.28
66.70
229.32
Depreciation
37.38
37.41
43.39
50.95
27.97
43.73
16.69
Profit Before Tax
2.52
63.66
36.01
47.30
-10.54
796.64
173.33
Tax
6.55
9.84
41.23
-9.84
-7.55
167.34
30.01
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-4.03
53.82
-5.22
57.14
-2.98
629.30
143.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-4.03
53.82
-5.22
57.14
-2.98
629.30
143.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-4.03
53.82
-5.22
57.14
-2.98
629.30
143.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
830.44
700.91
597.49
821.16
709.52
767.23
560.91
Earnings per share (EPS)
-0.22
2.94
-1.98
3.31
-0.18
31.85
5.96
Diluted Earnings per share
-0.22
2.94
-1.98
3.31
-0.18
31.85
5.96
Operating Profit Margin (Excl OI)
13.77%
7.48%
6.54%
14.9%
4.68%
-4.76%
65.11%
Gross Profit Margin
23.87%
76.97%
40.46%
35.45%
9.35%
698.67%
75.57%
PAT Margin
-2.41%
40.98%
-2.66%
20.62%
-1.6%
523.19%
57.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 27.27% vs -33.08% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -107.43% vs 1,134.62% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 27.97% vs -16.01% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 328.57% vs -61.11% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Ligand Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
167.13
131.16
35.97
27.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
167.13
131.16
35.97
27.42%
Raw Material Cost
46.33
5.28
41.05
777.46%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.04
0.00
3.04
Selling and Distribution Expenses
81.55
115.45
-33.90
-29.36%
Other Expenses
1.84
22.77
-20.93
-91.92%
Total Expenditure (Excl Depreciation)
149.31
348.43
-199.12
-57.15%
Operating Profit (PBDIT) excl Other Income
17.82
-217.27
235.09
108.20%
Other Income
74.85
128.92
-54.07
-41.94%
Operating Profit (PBDIT)
135.25
-86.32
221.57
256.68%
Interest
3.04
0.00
3.04
Exceptional Items
-92.31
0.00
-92.31
Gross Profit (PBDT)
120.80
125.88
-5.08
-4.04%
Depreciation
37.38
2.03
35.35
1,741.38%
Profit Before Tax
2.52
-88.35
90.87
102.85%
Tax
6.55
7.14
-0.59
-8.26%
Provisions and contingencies
0
0
0.00
Profit After Tax
-4.03
-95.50
91.47
95.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-4.03
-95.50
91.47
95.78%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-4.03
-95.50
91.47
95.78%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
830.44
502.75
327.69
65.18%
Earnings per share (EPS)
-0.22
-1.02
0.80
78.43%
Diluted Earnings per share
-0.22
-1.02
0.80
78.43%
Operating Profit Margin (Excl OI)
13.77%
-165.65%
0.00
179.42%
Gross Profit Margin
23.87%
-65.81%
0.00
89.68%
PAT Margin
-2.41%
-72.81%
0.00
70.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 16.71 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 27.27% vs -33.08% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -0.40 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -107.43% vs 1,134.62% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.04 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 27.97% vs -16.01% in Dec 2023
Annual - Interest
Interest 0.30 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 328.57% vs -61.11% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.77%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
